Raltegravir-associated Drug-Reaction With Eosinophilia and Systemic Symptoms Syndrome in a Pediatric Patient Without Characteristic Human Leukocyte Antigen B*57:01 or B*53:01 alleles
- PMID: 32766769
- PMCID: PMC8023309
- DOI: 10.1093/jpids/piaa089
Raltegravir-associated Drug-Reaction With Eosinophilia and Systemic Symptoms Syndrome in a Pediatric Patient Without Characteristic Human Leukocyte Antigen B*57:01 or B*53:01 alleles
Abstract
We present the first published case of raltegravir-associated drug-reaction with eosinophilia and systemic symptoms (DRESS) syndrome in a child without characteristic human leukocyte antigen haplotypes HLA-B*57:01 or HLA-B*53:01. A 4-year-old African American female with perinatally acquired human immunodeficiency virus infection was hospitalized for DRESS after starting a raltegravir-based antiretroviral regimen.
Keywords: antiretroviral therapy; drug-reaction with eosinophilia and systemic symptoms syndrome; human immunodeficiency virus; human leukocyte antigen-B alleles; raltegravir.
© The Author(s) 2020. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
Association of the HLA-B*53:01 Allele With Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome During Treatment of HIV Infection With Raltegravir.Clin Infect Dis. 2017 May 1;64(9):1198-1203. doi: 10.1093/cid/cix096. Clin Infect Dis. 2017. PMID: 28369189 Free PMC article.
-
Rate of DRESS Syndrome With Raltegravir and Role of the HLA-B*53: 01 Allele.J Acquir Immune Defic Syndr. 2020 Dec 1;85(4):e77-e80. doi: 10.1097/QAI.0000000000002474. J Acquir Immune Defic Syndr. 2020. PMID: 33136758 No abstract available.
-
Raltegravir-induced drug reaction with eosinophilia and systemic symptoms syndrome in a child.Ann Allergy Asthma Immunol. 2016 Dec;117(6):719-721. doi: 10.1016/j.anai.2016.09.433. Epub 2016 Oct 27. Ann Allergy Asthma Immunol. 2016. PMID: 28073704 No abstract available.
-
Drug Reaction with Eosinophilia and Systemic Symptoms: A Complex Interplay between Drug, T Cells, and Herpesviridae.Int J Mol Sci. 2021 Jan 23;22(3):1127. doi: 10.3390/ijms22031127. Int J Mol Sci. 2021. PMID: 33498771 Free PMC article. Review.
-
Drug-reaction eosinophilia and systemic symptoms and drug-induced hypersensitivity syndrome.Australas J Dermatol. 2014 Feb;55(1):15-23. doi: 10.1111/ajd.12085. Epub 2013 Jul 19. Australas J Dermatol. 2014. PMID: 23866082 Review.
References
-
- Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: part I. Clinical perspectives. J Am Acad Dermatol 2013; 68:693 e1–14; quiz 706–8. - PubMed
-
- Cacoub P, Musette P, Descamps V, et al. . The DRESS syndrome: a literature review. Am J Med 2011; 124:588–97. - PubMed
-
- Mallal S, Nolan D, Witt C, et al. . Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet 2002; 359:727–32. - PubMed